New therapy option identified for early-stage breast cancer
Wednesday, February 5, 2020 - 14:00
in Health & Medicine
Radionuclide therapy has been successful in delaying the growth of disseminated tumor cells in early-stage breast cancer. Radium-233 dichloride not only impacts cells directly hit by radiation but also has significant effects on cells outside of the radiation field, according to new research.